W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
Financial Figures/Balance Sheet / WORLD OF MEDICINE: Due to preliminary numbers turnover and outcome of 3rd Quarter below plan/ Year end targets are at risk/ Cost reduction will be expanded/ Launch of important n

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- 21.10.2005 (Berlin, October 21st, 2005) Revenues of medical device producer WORLD OF MEDICINE turned out to be under plan in the 3rd quarter 2005, mainly caused by the postponed launch of an important new product to the end of the 3rd quarter as well as a difficult market environment in Europe. Turnover in USA developed positively further on. Compared to last year’s revenues for the first nine month of the year, group revenues decreased by 13,1 % to 21,6 Mio. EUR. The group result was influenced mainly by severance payments, closing costs for the facility in Gröbenzell and partial write offs in inventory and mounted to -0,8 Mio. EUR for the nine month period. Due to the unexpected development of revenues and the temporarily delayed effects of cost cuts the positive income for the year as stated at the beginning of the year is expected to be missed. Additional actions for cost reduction and efficiency increase will be worked out by the Board of directors soon. Increase of turnover is expected in 2006 based on launches of new products. The 3rd quarter report will be introduced November 14th, 2005, as planned. Board of Directors WORLD OF MEDICINE and its technologies are paving the way for innovative procedures in Minimally Invasive Surgery - or MIS® for short. WORLD OF MEDICINE markets the products from its core business, MIS®, through major medical technology firms and established distributors. WORLD OF MEDICINE exports more than 60 % of its products, and in the future will also profit from the strong growth markets outside of Europe. More than 40 % of sales are conducted in the U.S., the world’s largest medical technology market. In addition to this, WORLD OF MEDICINE has made well-timed investments in the new markets opening in Asia, especially China. WORLD OF MEDICINE’s 30 years of experience in MIS® is substantiated by the 50 % global market share it holds in its core business, Flow&FluidWORLD®, its long standing relationships with more than 200 business partners, over 35 FDA approvals, more than 50 patents and the high quality offered by its production facility in Ludwigsstadt, Germany. The Stock Of WORLD OF MEDICINE® (ISIN DE 0006637390) is listed in the Prime Standard in the Frankfurt stock exchange and in the German Entrepreneurial Index (GEX). end of announcement euro adhoc 21.10.2005 18:12:11 -------------------------------------------------------------------------------- ots Originaltext: W.O.M. World of Medicine AG Im Internet recherchierbar: http://www.presseportal.de Further inquiry note: Verena Zahn Tel.: +49 (0)30 3998155 642 verena.zahn@womcorp.com Branche: Pharmaceuticals ISIN: DE0006637390 WKN: 663739 Index: Prime Standard, CDAX, Prime All Share, Technologie All Share Börsen: Frankfurter Wertpapierbörse / regulated dealing Berliner Wertpapierbörse / free trade Hamburger Wertpapierbörse / free trade Baden-Württembergische Wertpapierbörse / free trade Börse Düsseldorf / free trade Bayerische Börse / free trade Bremer Wertpapierbörse (BWB) / free trade

Das könnte Sie auch interessieren: